News

With the Markey Cancer Center, Ellingson uses molecular docking as a filtering process to efficiently and safely screen potential drugs before real-world experiments begin.

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

In its ongoing efforts to offer Kentuckians the latest, most innovative cancer treatments available, the UK Markey Cancer Center recently launched the Precision Medicine Clinic, a new space dedicated to providing patients with increased access to phase I and phase II clinical trials.

The Markey Cancer Foundation invites you to take an active role in furthering life-changing cancer research at the University of Kentucky Markey Cancer Center through the 'Markey Women Strong' program.

A new collaboration using resources from the UK Markey Cancer Center, FCC, NCI, and more will evaluate how to use telecommunications to improve access to cancer care for patients in Eastern Kentucky.

Communities with strong smoke-free workplace laws report lower number of new lung cancer diagnoses

In a prime example of the unique type of cross-collaboration that takes place at academic medical centers, Markey's stem cell lab is working together with the Kentucky Neuroscience Institute to bring an innovative stroke clinical trial to UK HealthCare.

New findings from University of Kentucky faculty published in Scientific Reports reveals a novel cell signaling interaction that may prevent a key step in lung cancer progression.

Kip Guy shares his research on neglected diseases, his goals as dean of the College of Pharmacy, and how pharmacy researchers are addressing the opioid epidemic.

The University of Kentucky Markey Cancer Center has joined the Oncology Research Information Exchange Network® (ORIEN), a personalized medicine consortium that allows its members to exchange data and push forward evidence-based cancer care to patients.